Cosmecca Korea Toekomstige groei
Future criteriumcontroles 4/6
Cosmecca Korea zal naar verwachting groeien in winst en omzet met respectievelijk 23.4% en 15.8% per jaar. De winst per aandeel zal naar verwachting groeien met 24.4% per jaar. Het rendement op het eigen vermogen zal over 3 jaar naar verwachting 20.5% zijn.
Belangrijke informatie
23.4%
Groei van de winst
24.4%
Groei van de winst per aandeel
Personal Products winstgroei | 10.1% |
Inkomstengroei | 15.8% |
Toekomstig rendement op eigen vermogen | 20.5% |
Dekking van analisten | Good |
Laatst bijgewerkt | 11 Nov 2024 |
Recente toekomstige groei-updates
Recent updates
Is There Now An Opportunity In Cosmecca Korea Co., Ltd. (KOSDAQ:241710)?
Nov 25Why The 20% Return On Capital At Cosmecca Korea (KOSDAQ:241710) Should Have Your Attention
Nov 11Cosmecca Korea Co., Ltd.'s (KOSDAQ:241710) Intrinsic Value Is Potentially 73% Above Its Share Price
Aug 29Is Now The Time To Look At Buying Cosmecca Korea Co., Ltd. (KOSDAQ:241710)?
Aug 07Cosmecca Korea Co., Ltd. (KOSDAQ:241710) Looks Just Right With A 54% Price Jump
Jun 24With EPS Growth And More, Cosmecca Korea (KOSDAQ:241710) Makes An Interesting Case
Jun 16Market Participants Recognise Cosmecca Korea Co., Ltd.'s (KOSDAQ:241710) Revenues Pushing Shares 29% Higher
May 10Is Cosmecca Korea Co., Ltd. (KOSDAQ:241710) Trading At A 44% Discount?
Apr 19Cosmecca Korea Co., Ltd. (KOSDAQ:241710) Shares Slammed 27% But Getting In Cheap Might Be Difficult Regardless
Mar 25We Like These Underlying Return On Capital Trends At Cosmecca Korea (KOSDAQ:241710)
Mar 01Cosmecca Korea Co., Ltd.'s (KOSDAQ:241710) Intrinsic Value Is Potentially 37% Above Its Share Price
Mar 23Cosmecca Korea (KOSDAQ:241710) Share Prices Have Dropped 53% In The Last Three Years
Mar 04When Should You Buy Cosmecca Korea Co., Ltd. (KOSDAQ:241710)?
Feb 17The Returns At Cosmecca Korea (KOSDAQ:241710) Provide Us With Signs Of What's To Come
Feb 02Should You Use Cosmecca Korea's (KOSDAQ:241710) Statutory Earnings To Analyse It?
Jan 18Is Cosmecca Korea (KOSDAQ:241710) Using Too Much Debt?
Jan 04What You Need To Know About Cosmecca Korea Co., Ltd.'s (KOSDAQ:241710) Investor Composition
Dec 23Are Investors Undervaluing Cosmecca Korea Co., Ltd. (KOSDAQ:241710) By 32%?
Dec 08Cosmecca Korea's (KOSDAQ:241710) Stock Price Has Reduced 58% In The Past Three Years
Nov 25Winst- en omzetgroeiprognoses
Datum | Inkomsten | Inkomsten | Vrije kasstroom | Geldmiddelen uit operationele activiteiten | Gem. Aantal analisten |
---|---|---|---|---|---|
12/31/2026 | 737,762 | 61,340 | 54,170 | 73,876 | 6 |
12/31/2025 | 640,062 | 49,383 | 41,670 | 58,939 | 8 |
12/31/2024 | 547,855 | 41,367 | 31,400 | 50,600 | 6 |
9/30/2024 | 518,722 | 35,651 | 13,540 | 53,506 | N/A |
6/30/2024 | 508,494 | 34,448 | 7,843 | 42,726 | N/A |
3/31/2024 | 480,375 | 26,635 | 7,706 | 32,582 | N/A |
12/31/2023 | 470,719 | 22,319 | 23,246 | 41,969 | N/A |
9/30/2023 | 454,429 | 17,991 | 33,974 | 50,052 | N/A |
6/30/2023 | 441,574 | 11,346 | 30,045 | 44,224 | N/A |
3/31/2023 | 426,334 | 7,151 | 25,430 | 38,063 | N/A |
12/31/2022 | 399,399 | 2,656 | 4,911 | 16,695 | N/A |
9/30/2022 | 386,671 | 3,584 | 481 | 8,358 | N/A |
6/30/2022 | 380,431 | 6,114 | -961 | 6,684 | N/A |
3/31/2022 | 391,991 | 6,919 | 519 | 8,499 | N/A |
12/31/2021 | 396,466 | 8,904 | -1,294 | 7,888 | N/A |
9/30/2021 | 383,994 | 7,478 | -11,022 | 372 | N/A |
6/30/2021 | 364,225 | 3,676 | 4,356 | 15,544 | N/A |
3/31/2021 | 343,194 | 2,459 | -5,861 | 8,796 | N/A |
12/31/2020 | 339,056 | 2,622 | -3,035 | 11,910 | N/A |
9/30/2020 | 341,779 | 1,850 | -3,482 | 14,849 | N/A |
6/30/2020 | 342,620 | 3,097 | -12,069 | 9,080 | N/A |
3/31/2020 | 351,242 | 5,818 | -9,302 | 14,857 | N/A |
12/31/2019 | 347,018 | 4,866 | -11,607 | 19,353 | N/A |
9/30/2019 | 338,290 | 2,715 | -12,430 | 24,402 | N/A |
6/30/2019 | 355,203 | 4,106 | -40,557 | 8,414 | N/A |
3/31/2019 | 335,242 | 8,090 | -27,271 | 17,598 | N/A |
12/31/2018 | 303,293 | 8,972 | -32,228 | 10,837 | N/A |
9/30/2018 | 272,601 | 12,943 | -34,658 | 6,496 | N/A |
6/30/2018 | 214,660 | 11,601 | N/A | 16,409 | N/A |
3/31/2018 | 184,919 | 8,488 | N/A | 5,796 | N/A |
12/31/2017 | 182,328 | 9,934 | N/A | 10,441 | N/A |
9/30/2017 | 182,438 | 11,919 | N/A | 11,074 | N/A |
6/30/2017 | 187,953 | 13,176 | N/A | 2,568 | N/A |
3/31/2017 | 181,618 | 12,240 | N/A | 6,973 | N/A |
12/31/2016 | 165,176 | 11,505 | N/A | 4,401 | N/A |
9/30/2016 | 147,204 | 9,708 | N/A | 4,281 | N/A |
6/30/2016 | 131,028 | 8,865 | N/A | 9,353 | N/A |
3/31/2016 | 110,391 | 6,347 | N/A | 2,698 | N/A |
12/31/2015 | 99,150 | 5,027 | N/A | 2,703 | N/A |
12/31/2014 | 68,318 | 1,355 | N/A | 4,651 | N/A |
Toekomstige groeivoorspellingen analisten
Verdiensten versus spaarpercentage: De verwachte winstgroei A241710 ( 23.4% per jaar) ligt boven de spaarquote ( 2.7% ).
Winst versus markt: De winst van A241710 ( 23.4% per jaar) zal naar verwachting langzamer groeien dan de markt KR ( 29.2% per jaar).
Hoge groeiwinsten: De winst van A241710 zal naar verwachting de komende 3 jaar aanzienlijk groeien.
Omzet versus markt: De omzet van A241710 ( 15.8% per jaar) zal naar verwachting sneller groeien dan de markt KR ( 9.1% per jaar).
Hoge groei-inkomsten: De omzet van A241710 ( 15.8% per jaar) zal naar verwachting langzamer groeien dan 20% per jaar.
Groeiprognoses winst per aandeel
Toekomstig rendement op eigen vermogen
Toekomstige ROE: Het rendement op eigen vermogen A241710 zal naar verwachting over 3 jaar hoog zijn ( 20.5 %)